Researchers Map 60 Genetic Regions Linked to Liver Fat
The study identifies 31 new genetic markers, potentially improving future screening for fatty liver disease and cancer.
Updated on Oct. 21, 2026 in Life Sciences
Live Poll
Would you undergo genetic screening to understand your long-term risk of developing liver disease?
Researchers have identified 60 genetic regions linked to liver fat levels, including 31 not previously associated with fatty liver disease. This research, published in Nature Genetics, utilized MRI scans and genetic data from 71,488 individuals of European descent.
Why it matters
Identifying these genetic markers provides a new understanding of the biological drivers behind fatty liver disease. These findings could eventually inform better risk assessment for the disease and associated conditions like liver cancer.
The study analyzed MRI-derived liver fat measurements against genome-wide data from 71,488 participants. Researchers successfully pinpointed specific genes in 48 of the 60 identified regions that likely influence the development of fatty liver conditions.
The players
Karolinska Institutet
A research-led medical university that investigates complex genetic traits and metabolic diseases.
UK Biobank
A large-scale biomedical database that provides anonymized genetic and health data for research purposes.
The details
Researchers performed a genome-wide association study, a method that scans entire genomes to find variations linked to a specific trait, using data from the UK Biobank. By overlaying this genetic information with objective liver fat measurements from MRI scans, the team established a genetic risk scale. They then isolated genes within 48 of these 60 regions that appear to regulate how the liver stores fat, providing a mechanism for how these variants contribute to metabolic health.
Timeline
October 2026: The study was published in the journal Nature Genetics.
The Tech Race
This work follows a pattern set by large-scale genomic analyses using the UK Biobank to map polygenic traits. It significantly expands the genetic roadmap for metabolic disease compared to earlier, smaller-scale studies.
Individuals with high genetic risk scores for fatty liver disease may eventually benefit from more personalized screening and diagnostic programs. Currently, the findings remain at the research stage and do not yet offer direct clinical diagnostic tests for the public.
The takeaway
Genetic factors account for one-quarter of the variation in liver fat, highlighting a substantial target for metabolic research. Future studies will need to validate these 60 identified regions across non-European populations to ensure broader clinical utility.
Further reading
For more developments in hereditary health markers, visit Life Sciences.
More information
Review the full research findings in the Nature Genetics journal article.
Source note: This article includes information reported by News-Medical.
Live Poll
Would you undergo genetic screening to understand your long-term risk of developing liver disease?
